| Literature DB >> 25369057 |
Elvira Kuhn1, Xinyi Du2, Keith McGrath1, Sarah Coveney1, Niamh O'Regan1, Sarah Richardson3, Andrew Teodorczuk3, Louise Allan3, Dan Wilson4, Sharon K Inouye5, Alasdair M J MacLullich6, David Meagher7, Carol Brayne8, Suzanne Timmons1, Daniel Davis9.
Abstract
BACKGROUND: Delirium is increasingly considered to be an important determinant of trajectories of cognitive decline. Therefore, analyses of existing cohort studies measuring cognitive outcomes could benefit from methods to ascertain a retrospective delirium diagnosis. This study aimed to develop and validate such a method for delirium detection using routine medical records in UK and Ireland.Entities:
Mesh:
Year: 2014 PMID: 25369057 PMCID: PMC4219785 DOI: 10.1371/journal.pone.0111823
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Abstracted symptoms in relation to DSM-IV criteria.
| DSM-IV criterion | Abstracted symptoms |
| A. Disturbance of consciousness (i.e., reduced clarity of awareness of the environment) with reduced ability to focus, sustain or shift attention. | Agitation; drowsiness; any formal rating e.g. AVPU or GCS. Any verbatim comment, e.g. ‘drowsy’, ‘slept poorly’, ‘agitated’ |
| B. A change in cognition or the development of a perceptual disturbance that is not better accounted for by a pre-existing, established or evolving dementia. | Any formal cognitive assessment (AMT; MMSE) Any formal specialty assessment, e.g. neurology, geriatric medicine, liaison psychiatry. Any verbatim comment, e.g. ‘more confused’, ‘disorientated’ |
| C. The disturbance develops over a short period of time (usually hours to days) and tends to fluctuate during the course of the day | Observations at least three times daily (nursing). Any verbatim comment indicating change in mental state. |
| D. There is evidence from the history, physical examination or laboratory findings that the disturbance is caused by the direct physiological consequences of a general medical condition. | General clinical vignette, including metabolic and laboratory parameters taken closest to date of prevalence study: AVPU score; systolic blood pressure; pulse; respiratory rate; oxygen saturation; temperature; C-reactive protein; urea; creatinine. |
AVPU = assessment of arousal where categories are Alert, Verbally-responsive, Pain-responsive, Unresponsive.
GCS = Glasgow Coma Scale.
AMT = Abbreviated Mental Test.
MMSE = Mini-Mental State Examination.
Figure 1STARD flow diagram showing the numbers receiving the index test and reference standard.
TP true positive; TN true negative; FP false positive; FN false negative.
Characteristics of participants, by delirium status.
| DSM delirium (n = 29) | No DSM delirium (n = 66) | P value | |
| Age | 80.6 (74.9–88.6) | 68.2 (53.5–80.2) | 0.07 |
| Sex | 14 (50%) | 33 (50%) | 1.00 |
| Dementia | 6/9 | 3/22 | 0.01 |
| Co-morbidity score | 4 (2–6) | 2 (0–4) | 0.44 |
| Median CRP | 57.3 (13–121.2) | 37.0 (0—120.0) | 0.49 |
| Median Urea∶ creatinine | 0.11 (0.09–0.14) | 0.08 (0.06–0.10) | 0.45 |
| Median ViEWS | |||
| AVPU | A = 26/29 V/P/U = 3/29 | A = 66/66 | 0.03 |
| HR | 82.0 | 82.3 | 0.99 |
| RR | 19.5 | 18.7 | 0.31 |
| BP | 125 | 124 | 0.99 |
| Temp | 36.2 | 36.6 | 0.10 |
| Sa02 | 96 | 96 | 0.99 |
| Fi02 | Y = 6 N = 23 | Y = 9 N = 57 | 0.38 |
DSM delirium = reference standard delirium.
Dementia ascertained through IQCODE.
Co-morbidity score = Charlson co-morbidity index.
CRP C-reactive protein.
AVPU = assessment of arousal where categories are Alert, Verbally-responsive, Pain-responsive, Unresponsive.
Fi02 is scored as Y = supplemental oxygen; N = room air.
*Aggregate information derived from multiple vignettes, therefore the standard errors (not shown) are not robust to the clustered nature of the data. The p values are derived from estimates with robust standard errors.
Diagnostic test accuracy of the consensus method for delirium detection.
| Sensitivity | Specificity | LR+ | LR− | AUROC | |||||||||||
| LCI | UCI | LCI | UCI | LCI | UCI | LCI | UCI | LCI | UCI | ||||||
|
| |||||||||||||||
| Inattention | 0.68 | 0.63 | 0.72 | 0.86 | 0.83 | 0.89 | 4.83 | 3.59 | 6.58 | 0.38 | 0.32 | 0.45 | 0.77 | 0.73 | 0.81 |
| Change in cognition | 0.71 | 0.67 | 0.75 | 0.92 | 0.89 | 0.94 | 9.14 | 6.21 | 13.41 | 0.31 | 0.26 | 0.38 | 0.82 | 0.78 | 0.85 |
| Acute and fluctuating | 0.70 | 0.66 | 0.74 | 0.89 | 0.85 | 0.91 | 6.16 | 4.48 | 8.65 | 0.34 | 0.28 | 0.40 | 0.79 | 0.75 | 0.83 |
| Physiological precipitant | 0.68 | 0.63 | 0.72 | 0.82 | 0.78 | 0.86 | 3.83 | 2.91 | 5.01 | 0.39 | 0.33 | 0.47 | 0.75 | 0.71 | 0.79 |
|
| |||||||||||||||
| Before consensus | 0.84 | 0.80 | 0.87 | 0.77 | 0.72 | 0.80 | 3.62 | 2.91 | 4.46 | 0.21 | 0.16 | 0.27 | 0.85 | 0.81 | 0.88 |
| Final consensus | 0.89 | 0.85 | 0.91 | 0.75 | 0.71 | 0.79 | 3.54 | 2.90 | 4.32 | 0.15 | 0.11 | 0.21 | 0.86 | 0.82 | 0.89 |
| Subgroup aged ≥70 years | 0.88 | 0.83 | 0.92 | 0.68 | 0.62 | 0.73 | 2.74 | 2.17 | 3.43 | 0.18 | 0.12 | 0.27 | 0.82 | 0.77 | 0.87 |
| Subgroup with dementia | 0.88 | 0.69 | 0.96 | 0.57 | 0.39 | 0.76 | 2.06 | 1.13 | 3.90 | 0.21 | 0.06 | 0.80 | 0.69 | 0.51 | 0.85 |
|
| |||||||||||||||
| Before consensus | 0.63 | 0.58 | 0.67 | 0.92 | 0.89 | 0.94 | 7.97 | 5.30 | 11.62 | 0.40 | 0.35 | 0.47 | 0.85 | 0.81 | 0.88 |
| Final consensus | 0.58 | 0.50 | 0.62 | 0.93 | 0.90 | 0.95 | 7.80 | 5.65 | 11.96 | 0.46 | 0.40 | 0.47 | 0.86 | 0.82 | 0.89 |
| Subgroup aged ≥70 years | 0.54 | 0.48 | 0.60 | 0.90 | 0.85 | 0.93 | 5.33 | 3.23 | 8.49 | 0.51 | 0.43 | 0.61 | 0.82 | 0.77 | 0.87 |
| Subgroup with dementia | 0.71 | 0.51 | 0.85 | 0.57 | 0.39 | 0.76 | 1.65 | 0.83 | 3.47 | 0.51 | 0.20 | 1.27 | 0.69 | 0.51 | 0.85 |
LR Likelihood ratio; AUROC area under the curve, LCI lower 95% confidence interval; UCI upper 95% confidence interval.